Azatadine
From Infogalactic: the planetary knowledge core
File:Azatadine.svg | |
Systematic (IUPAC) name | |
---|---|
11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-
5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
|
Clinical data | |
Trade names | Optimine |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy category |
|
Legal status |
|
Identifiers | |
CAS Number | 3964-81-6 |
ATC code | R06AX09 (WHO) |
PubChem | CID: 19861 |
IUPHAR/BPS | 7119 |
DrugBank | DB00719 |
ChemSpider | 18709 |
UNII | 94Z39NID6C |
KEGG | D07482 |
ChEBI | CHEBI:2946 |
ChEMBL | CHEMBL946 |
Chemical data | |
Formula | C20H22N2 |
Molecular mass | 290.402 g/mol |
|
|
|
|
(verify) |
Azatadine (Optimine) is a first-generation antihistamine and anticholinergic that was launched Schering-Plough in 1973.[1][2]
It was patented in 1967.[3] It has been succeeded by other antihistamines[4]:53 and marketing approvals have been widely withdrawn.[5][6][7][8]:290[9]
See also
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Azatadine, Villani, F. J.; Caldwell, W. U.S. Patent 3,326,924 (1967).
- ↑ Horak F. Antialergic and Vasoactive Drugs for Allergic Rhinitis. Chapter 4 in Allergy Frontiers:Therapy and Prevention. Volume 5 of Allergy Frontiers. Eds Pawankar R et al Springer Science & Business Media, 2010 ISBN 9784431993629
- ↑ Drugs.com Drugs.com listing for Azatadine Page accessed July 3, 2015
- ↑ Federal Register 2005 Food and Drug Administration Docket No.2005N-0058: Hospira, Inc. et al.; Withdrawal of Approval of 76 New Drug Applications and 60 Abbreviated New Drug Applications 70 FR 10651
- ↑ Federal Register 2007 Food and Drug Administration Docket No. 2004P-0262: Withdrawal of Approval of 128 Suitability Petitions 72 FR 8184
- ↑ Department of Economic and Social Affairs of the United Nations Secretariat Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or not Approved by Governments Twelfth Issue: Pharmaceuticals United Nations – New York, 2005
- ↑ FDA OGD Suitability Tracking Report (Sorted by Drug Name) Page accessed July 3, 2015
<templatestyles src="Asbox/styles.css"></templatestyles>